🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
230.26
-6.19 (-2.62%)
At close: Nov 20, 2026, 4:00 PM EST
230.62
+0.36 (0.16%)
After-hours: Nov 20, 2026, 7:30 PM EST

Jazz Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,0361,3922,4131,506881.48591.45
Short-Term Investments
8201,050580120--
Trading Asset Securities
--0.963.78--
Cash & Short-Term Investments
2,8562,4422,9941,630881.48591.45
Cash Growth
39.60%-18.44%83.66%84.93%49.04%-72.27%
Receivables
873.7830.75716.77705.79651.49563.36
Inventory
454416.96480.45597.04714.061,073
Prepaid Expenses
170.9152.48177.41185.4891.91131.41
Other Current Assets
258.4323.95260.58317.03267.19252.39
Total Current Assets
4,6134,1664,6293,4352,6062,611
Property, Plant & Equipment
292258.74227234.99301.38343.42
Long-Term Investments
15.64.34.334.75.55
Goodwill
1,8031,8291,7161,7531,6931,828
Other Intangible Assets
4,1744,4304,7565,4185,7947,152
Long-Term Deferred Tax Assets
998.7869.13560.25477.83376.25311.1
Long-Term Deferred Charges
6.17.559.496.489.2512.03
Other Long-Term Assets
95.494.73110.1562.7649.6435.81
Total Assets
11,99811,65912,01211,39310,83512,299

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
380.3122.0677.87102.7590.76100.3
Accrued Expenses
1,011974.51821.98748.21757.86588.41
Current Portion of Long-Term Debt
1,0171,03031604.953146.23
Current Portion of Leases
14.914.7214.7819.4515.9415.76
Current Income Taxes Payable
59.256.3918.7635.077.729.61
Current Unearned Revenue
----0.462.09
Other Current Liabilities
50.244.9574.1926.2629.4646.9
Total Current Liabilities
2,5332,2431,0391,537933.19809.3
Long-Term Debt
4,5524,3286,0785,1115,6936,019
Long-Term Leases
60.754.3343.564.2677.0593.47
Long-Term Unearned Revenue
-----0.46
Long-Term Deferred Tax Liabilities
506.1594.47676.74847.71944.341,301
Other Long-Term Liabilities
153.8121.0882.0596.3101.6110.73
Total Liabilities
7,8067,3417,9197,6567,7508,333

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
-0.010.010.010.010.01
Additional Paid-In Capital
4,4144,2403,9143,7003,4773,535
Retained Earnings
423.6646.181,127878.66733.59830.23
Comprehensive Income & Other
-646-568.07-947.14-841.62-1,125-399.83
Shareholders' Equity
4,1924,3194,0943,7373,0863,965
Total Liabilities & Equity
11,99811,65912,01211,39310,83512,299

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
5,6455,4276,1675,8005,8176,174
Net Cash (Debt)
-2,789-2,985-3,173-4,170-4,936-5,583
Net Cash Growth
------
Net Cash Per Share
-41.82-48.96-48.07-57.86-78.92-93.53
Filing Date Shares Outstanding
64.1961.5660.7362.3563.3361.74
Total Common Shares Outstanding
64.161.4460.6362.2663.2161.63
Working Capital
2,0801,9243,5901,8991,6731,802
Book Value Per Share
65.3970.3067.5260.0348.8264.34
Tangible Book Value
-1,785-1,940-2,378-3,434-4,401-5,015
Tangible Book Value Per Share
-27.84-31.58-39.22-55.16-69.63-81.36
Land
71.972.2371.970.9168.9464.01
Machinery
131.6129.33116.14107.57100.4999.73
Construction In Progress
83.149.6434.4918.6667.3986.51
Leasehold Improvements
6863.5770.267.7264.7866.32
SEC Filings: 10-K · 10-Q